Spartan Submits COVID-19 Testing System to Health Canada for Investigational Testing Authorization (ITA)

September 21st, 2020

Spartan Bioscience has commenced the regulatory process of its revised COVID-19 point-of-care test and submitted an Investigational Testing Authorization (ITA) application to Health Canada for its review and approval. Upon approval, Spartan will commence...

Read more

Spartan Concludes Covid-19 Test Fix; Prepares for Re-Submission to Health Canada

August 13th, 2020

Spartan Bioscience has developed a fix to our COVID-19 test and is preparing for re-submission to Health Canada. The delay has allowed us to incorporate the latest information on COVID-19 and conclude 12 weeks of intense work where we tested approximately...

Read more

Spartan Bioscience Expands Executive Team

June 12th, 2020

Ottawa-Spartan Bioscience is pleased to announce the expansion of its executive team to provide critical leadership for the company’s recent rapid growth, as well as its focus on supporting Canada’s response to COVID-19. Patrick (Pat) J. Mallon, a member...

Read more

Spartan’s COVID-19 Test: Swab Update

June 2nd, 2020

Ottawa-On May 1, 2020 Health Canada informed Spartan of challenges with our proprietary swab’s ability to collect a sufficient sample to conduct Spartan’s COVID-19 test. The same report confirmed the accuracy and analytical performance of Spartan’s test c...

Read more

The University of Ottawa Heart Institute Receives Funding for COVID-19 Research Using Spartan’s Test

May 25th, 2020

Ottawa-Spartan Bioscience is excited to announce our collaboration with the University of Ottawa Heart Institute’s research into point-of-care testing for COVID-19 has received support from the Government of Ontario. Premier Doug Ford made the announcemen...

Read more